This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept
Welcome to PATH
We are a global nonprofit improving public health.
About us

Public health across sectors

We forge partnerships across sectors and borders, with governments and philanthropists, nonprofits and the private sector. We’ve been doing it for more than 40 years.

Focused on equity

Everyone deserves the chance to live a healthy life. With the help of our partners, we develop, adapt, and scale up solutions to accelerate progress toward health equity.

We're responding to COVID-19

As COVID-19 spreads around the world, we are working to lessen its impact. Our experts are partnering with governments to establish emergency operations centers; advise on testing, treating, and managing the outbreak; and stand up digital and data systems that support real-time disease surveillance.

Learn More
By the numbers
A snapshot of PATH’s reach, team, and impact
70+
countries where PATH is improving health.
95%
of us are from the places where we work.
150M
lives improved by our work every year.

Support the global response

COVID-19 is a public health emergency.

The world is in the middle of a public health emergency. PATH is supporting the global response to COVID-19, from readying health systems for outbreaks to developing and deploying digital tools, point-of-care tests, drugs, vaccines, and more. You can help.

Donate now
Recent articles
Read our latest
View all articles
Projection of the Sustainable Development Goals on UNHQ in New York.
Uniting against COVID-19: PATH at the 75th UN General Assembly
Rukamini’s infant receives an oral polio vaccine (OPV) in Madhya Pradesh, India. Intestinal immunity is a key feature of OPV and other vaccines, and the adjuvant dmLT could help enhance this effect. Path/Gabe Bienczycki.
A secret ingredient for stronger vaccines?
A congested settlement in Mumbai, India. Photo: PATH/Ruhani Kaur.
Q&A: Pursuing equity in urban health
Drawing blood for a COVID-19 antibody test. Photo: Ministerio de Defensa del Perú
What can COVID-19 antibody tests really tell us?
20585.jpg Gordon Perkin, PATH's first persident and CEO, at a 2016 video interview. Photo: PATH
In memory of Gordon Perkin
Serum Institute produces its India- and WHO-approved pneumococcal conjugate vaccine at a state-of-the-art facility in Pune, India. Photo: Katherine De Bruyn.
Vaccine options for preventing pneumonia just got better in India
Liya Wondwossen has dedicated her career to expanding HPV vaccine access in Ethiopia. Photo: PATH.
In Ethiopia, Liya Wondwossen champions cervical cancer prevention
Illus-Virus-Globe-COVID-1440-sq.jpg
Fact or fiction: Navigating the infodemic